Lord, Abbett & Co’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.46M | Sell |
400,743
-65,272
| -14% | -$727K | 0.01% | 470 |
|
|
2025
Q1 | $5.73M | Buy |
+466,015
| New | +$5.73M | 0.02% | 443 |
|
|
2022
Q1 | – | Sell |
-355,972
| Closed | -$3.59M | – | 662 |
|
|
2021
Q4 | $3.59M | Sell |
355,972
-3,449
| -1% | -$34.8K | 0.01% | 571 |
|
|
2021
Q3 | $5.7M | Buy |
359,421
+112,053
| +45% | +$1.78M | 0.01% | 582 |
|
|
2021
Q2 | $5.89M | Buy |
+247,368
| New | +$5.89M | 0.01% | 600 |
|